INFUSYSTEM HOLDINGS, INC Operating Lease Cost
INFUSYSTEM HOLDINGS, INC (INFU) reported Operating Lease Cost of $476.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC operating lease, cost for the quarter ending 2026-06-30 was $476.00K, a 7.39% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC operating lease, cost for the quarter ending 2026-03-31 was $462.00K, a 7.97% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC operating lease, cost for the quarter ending 2025-12-31 was $485.00K, a 0.41% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC operating lease, cost for the quarter ending 2025-09-30 was $488.00K, a 2.09% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC operating lease, cost for fiscal 2025 was $1.99M, a 4.14% increase from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC operating lease, cost for fiscal 2024 was $1.91M, a 26.99% increase from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC operating lease, cost for fiscal 2023 was $1.50M, a 12.83% increase from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC operating lease, cost for fiscal 2022 was $1.33M, a 1.29% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $476.00K 10-Q · filed 2026-08-04 | $938.00K 10-Q · filed 2026-08-04 | $1.42M derived: sum of 3 quarters · filed 2026-08-04 | $1.91M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $462.00K 10-Q · filed 2026-05-08 | $947.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.44M derived: sum of 3 quarters · filed 2026-05-08 | $1.95M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $485.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $973.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.49M derived: sum of 3 quarters · filed 2026-08-04 | $1.99M 10-K · filed 2026-02-27 |
| 2025-09-30 | $488.00K 10-Q · filed 2025-11-04 | $1.00M derived: sum of 2 quarters · filed 2026-08-04 | $1.50M 10-Q · filed 2025-11-04 | $1.99M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $514.00K 10-Q · filed 2026-08-04 | $1.02M 10-Q · filed 2026-08-04 | $1.50M derived: sum of 3 quarters · filed 2026-08-04 | $1.98M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $502.00K 10-Q · filed 2026-05-08 | $989.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.47M derived: sum of 3 quarters · filed 2026-05-08 | $1.94M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $487.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $965.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.44M derived: sum of 3 quarters · filed 2026-02-27 | $1.91M 10-K · filed 2026-02-27 |
| 2024-09-30 | $478.00K 10-Q · filed 2025-11-04 | $950.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.42M 10-Q · filed 2025-11-04 | $1.83M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $472.00K 10-Q · filed 2025-08-05 | $945.00K 10-Q · filed 2025-08-05 | $1.35M derived: sum of 3 quarters · filed 2025-08-05 | $1.73M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $473.00K 10-Q · filed 2025-05-08 | $878.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.26M derived: sum of 3 quarters · filed 2025-05-08 | $1.63M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $405.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $783.00K derived: sum of 2 quarters · filed 2025-03-11 | $1.15M derived: sum of 3 quarters · filed 2025-03-11 | $1.50M 10-K · filed 2025-03-11 |
| 2023-09-30 | $378.00K 10-Q · filed 2024-11-08 | $747.00K derived: sum of 2 quarters · filed 2024-11-08 | $1.10M 10-Q · filed 2024-11-08 | $1.43M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $369.00K 10-Q · filed 2024-08-09 | $721.00K 10-Q · filed 2024-08-09 | $1.05M derived: sum of 3 quarters · filed 2024-08-09 | $1.39M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $352.00K 10-Q · filed 2024-05-09 | $679.00K derived: sum of 2 quarters · filed 2024-05-09 | $1.02M derived: sum of 3 quarters · filed 2024-05-09 | $1.36M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $669.00K derived: sum of 2 quarters · filed 2024-04-10 | $1.00M derived: sum of 3 quarters · filed 2024-04-10 | $1.33M 10-K · filed 2024-04-10 |
| 2022-09-30 | $342.00K 10-Q · filed 2023-11-09 | $677.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.01M 10-Q · filed 2023-11-09 | $1.32M derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-06-30 | $335.00K 10-Q · filed 2023-08-09 | $664.00K 10-Q · filed 2023-08-09 | $982.00K derived: sum of 3 quarters · filed 2024-04-10 | $1.28M derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-03-31 | $329.00K 10-Q · filed 2023-05-09 | $647.00K derived: sum of 2 quarters · filed 2024-04-10 | $949.00K derived: sum of 3 quarters · filed 2024-04-10 | $1.30M derived: sum of 4 quarters · filed 2024-04-10 |
| 2021-12-31 | $318.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $620.00K derived: sum of 2 quarters · filed 2024-04-10 | $968.00K derived: sum of 3 quarters · filed 2024-04-10 | $1.32M 10-K · filed 2024-04-10 |
| 2021-09-30 | $302.00K 10-Q · filed 2022-11-08 | $650.00K derived: sum of 2 quarters · filed 2022-11-08 | $998.00K 10-Q · filed 2022-11-08 | $1.38M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $348.00K 10-Q · filed 2022-08-04 | $696.00K 10-Q · filed 2022-08-04 | $1.07M derived: sum of 3 quarters · filed 2023-03-16 | $1.49M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $348.00K 10-Q · filed 2022-05-05 | $727.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.14M derived: sum of 3 quarters · filed 2023-03-16 | $1.54M derived: sum of 4 quarters · filed 2023-03-16 |
| 2020-12-31 | $379.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $789.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.19M derived: sum of 3 quarters · filed 2023-03-16 | $1.62M 10-K · filed 2023-03-16 |
| 2020-09-30 | $410.00K 10-Q · filed 2021-11-15 | $814.00K derived: sum of 2 quarters · filed 2021-11-15 | $1.24M 10-Q · filed 2021-11-15 | $1.76M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $404.00K 10-Q · filed 2021-08-12 | $828.00K 10-Q · filed 2021-08-12 | $1.35M derived: sum of 3 quarters · filed 2022-03-15 | $1.88M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $424.00K 10-Q · filed 2021-05-10 | $947.00K derived: sum of 2 quarters · filed 2022-03-15 | $1.48M derived: sum of 3 quarters · filed 2022-03-15 | $1.77M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $523.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $1.06M derived: sum of 2 quarters · filed 2022-03-15 | $1.35M derived: sum of 3 quarters · filed 2022-03-15 | $1.95M 10-K · filed 2022-03-15 |
| 2019-09-30 | $533.00K 10-Q · filed 2020-11-13 | $823.00K derived: sum of 2 quarters · filed 2020-11-13 | $1.43M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $290.00K 10-Q · filed 2020-08-14 | $677.00K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $387.00K 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |